Sensitization to cisplatin action by step-down heating in cDDP-sensitive and -resistant cells

Area of Science:

• Oncology
• Biophysics
• Cancer Therapeutics

Background:

• Acquired resistance to cisplatin (cDDP) is a significant challenge in cancer therapy.
• Conventional hyperthermia (≥43°C) can reverse cDDP resistance but is clinically difficult to achieve.
• Step-down heating (high temperature pre-treatment followed by lower temperature) may enhance hyperthermia efficacy.

Purpose of the Study:

• To investigate the drug-sensitizing potential of a step-down heating schedule in cDDP-sensitive and -resistant cancer cells.
• To evaluate the impact of a short high-temperature pre-treatment on hyperthermia and cDDP cytotoxicity.
• To determine if step-down heating can overcome acquired cDDP resistance.

Main Methods:

• In vitro culture of murine and human tumor cells (cDDP-sensitive and -resistant).
• Application of a 10-minute pre-treatment at 44°C followed by hyperthermia at 41°C.
• Assessment of cytotoxicity of hyperthermia alone, cDDP alone, and combined treatments.

Main Results:

• A 10-minute 44°C pre-treatment enhanced the cytotoxicity of 41°C hyperthermia alone.
• The pre-treatment also sensitized cells to cDDP at 37°C but did not enhance cDDP sensitization at 41°C.
• Step-down heating did not reduce the cDDP-resistance factor in resistant cells.
• Total cytotoxicity was 10-fold higher than cDDP with 41°C alone, due to combined hyperthermic killing and cDDP sensitization.

Conclusions:

• Step-down hyperthermia shows potential for sensitizing cancer cells to cisplatin, even in resistant lines.
• This protocol significantly increases overall cytotoxicity through additive hyperthermic and cDDP-sensitizing effects.
• The findings suggest a clinically applicable strategy to improve cisplatin efficacy against resistant tumors.